New York (CNN Business) President Trump received a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment. Now the drugmaker's stock is up sharply -- and questions are swirling about the president's ties to Regeneron ' s billionaire CEO . The stock reached its highs of the day after Trump tweeted that he will be leaving the hospital Monday evening. Regeneron confirmed to CNN Business that one of the president's doctors made such a request to Regeneron and the FDA to approve administering the drug to Trump. One of the president's physicians made the request to Regeneron and the FDA.

Source: CNN October 05, 2020 16:21 UTC